KWC/H Knowlton Capital

Elixxer Ltd. Provides Corporate Update

Elixxer Ltd. Provides Corporate Update

MONTRÉAL, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Elixxer Ltd. (TSX-V: ELXR) (OTC-QB: ELIXF) (FRA: 2LQA) (“Elixxer” or (the “Company”) wishes to announce that it has been in discussions with YA II PN, Ltd. and Riverfort Global Opportunities PLC (the “Lenders”) over claims that Elixxer is in default under the terms of its previously announced convertible loan agreement with the Lenders (see press release dated March 17, 2020). Negotiations towards arriving at a resolution are ongoing; however, if such negotiations prove to be unsuccessful, it may result in the Lenders instituting default proceedings against the Company in order to recover amounts owing pursuant to the loan in the amount of US$1,078,698, including accrued interest thereon. Although Elixxer has so far made several attempts to settle matters with the Lenders, including negotiations on the repayment of the amount owed, including payments consisting of cash and shares, it does not have the ability at present to repay the full amount in cash.

In the event where the Lenders and the Company cannot come to an agreement, a default under the terms of the Lenders’ loan may trigger cross default provisions under the terms of the Company’s secured loan agreement of 2019, pursuant to which $3.6m is owed, and the secured loan agreement of 2020, pursuant to which $4m is owed, plus accrued interest, for a total of CDN$7,964,825.52 with AIP Convertible Private Debt Fund L.P. (“AIP”). In light of the Lenders’ position, AIP and Elixxer have entered into discussions in order to arrive at a solution including securities-for-debt conversion of amounts owed under the 2019 loan on substantially the same terms as previously announced by the Company on August 21, 2020, which referred to a price per share of $0.015 and a five-year warrant exercisable at $0.05 per share, all of which would be subject to shareholder and TSX Venture Exchange approval.

About Elixxer Ltd. ()

Elixxer is a Canadian public company listed on the TSX Venture Exchange (TSX-V: ELXR) and the US OTC-QB exchange (OTCQB: ELIXF).

Through its partners, Elixxer presently has significant interests in Australia, Jamaica, Switzerland, Italy and Canada.

For further information please contact: 

Ferras Zalt, Chairman and Interim CEO:  

Caution Regarding Press Releases

Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Notice Regarding Forward Looking Statements

This press release may contain forward-looking statements with respect to Elixxer and its operations, strategy, investments, financial performance and condition. These statements can generally be identified by use of forward-looking words such as “may”, “will”, “expect”, “estimate”, “anticipate”, “intends”, “believe” or “continue” or the negative thereof or similar variations. The actual results and performance of Elixxer could differ materially from those expressed or implied by such statements. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding future expectations. Some important factors that could cause actual results to differ materially from expectations include, among other things, general economic and market factors, competition, government regulation and the factors described under “Risk Factors and Risk Management” in Elixxer’s most recent Management’s Discussion and Analysis filed on SEDAR (). The cautionary statements qualify all forward-looking statements attributable to Elixxer and persons acting on its behalf. Unless otherwise stated, all forward-looking statements speak only as of the date of this press release, and Elixxer has no obligation to update such statements, except to the extent required by applicable securities laws.

 



EN
26/02/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Knowlton Capital

 PRESS RELEASE

Elixxer Ltd. Announces Amendment to Proposed Debt Settlement Transacti...

Elixxer Ltd. Announces Amendment to Proposed Debt Settlement Transactions MONTRÉAL, March 09, 2021 (GLOBE NEWSWIRE) -- Elixxer Ltd. (the “Corporation” or “Elixxer”) (TSX-V: ELXR and OTC-QB: ELIXF) wishes to announce that, in light of current market uncertainty and the further deterioration in the Corporation’s share price, the Corporation’s principal secured lender has requested that the debt settlement transactions announced on March 2, 2021 be effected at a price of $0.015 per share as opposed to the previously disclosed price of $0.02 per share. As a result of this amendment, $3,656,3...

 PRESS RELEASE

Elixxer Ltd. Announces Revised Debt Settlement Transactions

Elixxer Ltd. Announces Revised Debt Settlement Transactions MONTRÉAL, March 02, 2021 (GLOBE NEWSWIRE) -- Elixxer Ltd. (the “Corporation” or “Elixxer”) (TSX-V: ELXR and OTC-QB: ELIXF) announces revised terms of its proposed debt settlement transactions. The Corporation proposes to settle a total of $8,568,333 of debt owed by the Corporation through the issuance of securities. The debt to be settled includes $3,964,826, including interest and fees, owed to AIP Convertible Private Debt Fund LP (“AIP”) pursuant to a loan agreement dated November 8, 2019 (the “AIP Debt”). The Corporation prop...

 PRESS RELEASE

Elixxer Ltd. Provides Corporate Update

Elixxer Ltd. Provides Corporate Update MONTRÉAL, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Elixxer Ltd. (TSX-V: ELXR) (OTC-QB: ELIXF) (FRA: 2LQA) (“Elixxer” or (the “Company”) wishes to announce that it has been in discussions with YA II PN, Ltd. and Riverfort Global Opportunities PLC (the “Lenders”) over claims that Elixxer is in default under the terms of its previously announced convertible loan agreement with the Lenders (see press release dated March 17, 2020). Negotiations towards arriving at a resolution are ongoing; however, if such negotiations prove to be unsuccessful, it may result in ...

 PRESS RELEASE

Little Green Pharma selected to supply France’s medical cannabis pilot...

Little Green Pharma selected to supply France’s medical cannabis pilot program MONTRÉAL, Jan. 27, 2021 (GLOBE NEWSWIRE) -- Elixxer Ltd. (TSX-V: ELXR) (OTC-QB: ELIXF) (FRA: 2LQA) (“Elixxer” or the “company”) is pleased to share the latest achievements of its largest holding Little Green Pharma Ltd. (LGP). LGP has achieved the following major milestone validating our investment: The French Agency for the Safety of Medicines and Health Products (ANSM) has selected Little Green Pharma as 1 of 4 companies that will supply France’s medical cannabis pilot program. Under the program, participant...

 PRESS RELEASE

Elixxer Ltd. Announces Change in CEO

Elixxer Ltd. Announces Change in CEO MONTRÉAL, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Elixxer Ltd. (TSX-V: ELXR) (OTC-QB: ELIXF) (FRA: 2LQA) (“Elixxer” or (the “Company) announces that, effective immediately, Mazen Haddad has ceased to be the Company’s Chief Executive Officer. Mr. Haddad continues to serve as a non-executive director of the Company. The Board of Directors has named Mr. Ferras Zalt, the Company’s Chairman, to serve as the Interim Chief Executive Officer of Elixxer. About Elixxer Ltd. () Elixxer is a Canadian public company listed on the TSX Venture Exchange (TSX-V: ELXR) and...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch